Atazanavir/ritonavir and lamivudine/zidovudine
- Level
- Commodity
- Parent
- 51343800
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51343810This classification denotes a combination drug for treatment of HIV. This is for copackaged product. The first component, ATAZANAVIR, has a US FDA Unique Ingredient Identifier of QZU4H47A3S. The second component, RITONAVIR, has a US FDA Unique Ingredient Identifier of O3J8G9O825. The third component, LAMIVUDINE, has US FDA Unique Ingredient Identifier of 2T8Q726O95. The fourth component, ZIDOVUDINE, has US FDA Unique Ingredient Identifier of 4B9XT59T7S.
Same parent
Under 51343800 · 28Activities that produce or sell this
KBLI · 8Inherited from family 51340000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.